Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $1.1 million.

  • Bicycle Therapeutics' Other Non-Current Liabilities fell 8167.03% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 8167.03%. This contributed to the annual value of $1.1 million for FY2024, which is 7551.87% down from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Other Non-Current Liabilities is $1.1 million, which was down 8167.03% from $1.1 million recorded in Q2 2025.
  • Bicycle Therapeutics' Other Non-Current Liabilities' 5-year high stood at $6.0 million during Q3 2024, with a 5-year trough of $1.1 million in Q3 2025.
  • For the 5-year period, Bicycle Therapeutics' Other Non-Current Liabilities averaged around $3.3 million, with its median value being $3.3 million (2021).
  • As far as peak fluctuations go, Bicycle Therapeutics' Other Non-Current Liabilities surged by 4201.44% in 2021, and later crashed by 8167.03% in 2025.
  • Bicycle Therapeutics' Other Non-Current Liabilities (Quarter) stood at $3.3 million in 2021, then grew by 16.77% to $3.8 million in 2022, then rose by 19.59% to $4.6 million in 2023, then plummeted by 75.52% to $1.1 million in 2024, then dropped by 2.5% to $1.1 million in 2025.
  • Its Other Non-Current Liabilities was $1.1 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.